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Abstract
Background: The need for anticoagulation therapy (AC) in patients with subsegmental pulmonary embolism (SSPE)
diagnosed by computed tomography of the pulmonary arteries (CTPA) has been questioned, as these patients run
low risk for recurrent venous thromboembolism (VTE) during 3 months of follow-up. Whether this applies also to
patients with small PE diagnosed with pulmonary scintigraphy has not yet been evaluated, however.
Methods: We therefore retrospectively evaluated 54 patients (mean age 62 ± 19 years, 36 [67 %] women) with
small PE diagnosed by ventilation/perfusion singe photon emission computed tomography (V/P SPECT) who did
not receive conventional long-term AC.
Results: More than half of our patients (36[67 %]) received less than 48 h of AC, 11 (20 %) patients were treated for
2–14 days, and 7 (13 %) for 15–30 days. The majority (28 [52 %]) of our patients had a non-low simplified
pulmonary emboli severity index (S-PESI), and 7 (13 %) had malignancy. D-dimer was negative in 18 (33 %), positive
in 10 (19 %), and not analyzed in 28 (52 %) patients. Phlebography of the lower extremities had been performed
with negative result in one patient.
During 90 days of follow up no deaths or PE occurred. Seven patients were readmitted to hospital, whereof two
(2/54 [4 %]) were diagnosed with deep venous thrombosis (DVT) necessitating AC therapy.
Conclusion: In conclusion, withholding longterm AC therapy in patients with SSPE diagnosed by V/P SPECT
resulted in 4 % risk for recurrence of VTE during 90 days of follow up, and can therefore currently not be
recommended.
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Background
The annual incidence rates of deep venous thrombosis
(DVT) and pulmonary embolism (PE) are approximately
0.5–1 per 1000 inhabitants [1]. The clinical presentation
of PE extends from asymptomatic patients to shock
states, but most patients (95 %) are normotensive and
present with breathing difficulties or pleuritic pain [2].
The use of multiple-detector computed tomography pul-
monary angiography (CTPA), has led to an increased
number of diagnosed sub-segmental pulmonary emboli
(SSPE), accounting for around 5–15 % of PE cases [3].
Albeit CTPA is considered the primary diagnostic tool
for detection of PE and is available 24 h a day, 7 days a
week, there are alternative methods [4]. Using planar
ventilation-perfusion lung scan (V/Q scan), the majority
of patients with suspected PE have non-diagnostic exam-
inations [5]. Prospective management studies demon-
strated that patients with low or intermediate probability
V/Q scan, low pretest probability of PE, and negative
compression ultrasonography can be safely managed
without anticoagulation [6, 7]. Lung scintigraphy has
been further developed, however. Modern ventilation/
* Correspondence: Raein.Ghazvinian@skane.se
Lund University, Division of Vascular Medicine, Skåne University Hospital,
Ruth Lundskogs Gata 10, S-205 02 Malmö, Sweden
© 2016 Ghazvinian et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Ghazvinian et al. Thrombosis Journal  (2016) 14:12 
DOI 10.1186/s12959-016-0086-0
perfusion single photon emission computed tomography
(V/P SPECT) and “holistic” interpretation criteria reduce
the risk for non-diagnostic findings, and increases the
sensitivity and specificity for diagnosis of PE [8]. With
this technique PE can be classified as segmental or sub-
segmental and graded according to the percentage of the
pulmonary vascular bed affected [8].
Some diagnostic challenges persist, however. Even
though the use of multi-detector CTPA or V/P SPECT
in combination with diagnostic algorithms as for ex-
ample the Wells score [9] has increased the diagnostic
accuracy of PE, the mortality of the disease has remained
consistent [10–12]. This might indicate that many of the
small SSPE treated after detection with CTPA may be of
low clinical significance [4]. In fact, treatment of SSPE in
patients with high bleeding risk, and low risk for recur-
rent venous thromboembolism (VTE) might perhaps
even be contraindicated due to increased risk of bleeding
and other treatment complications. Whether it is safe to
withhold anticoagulant (AC) treatment in patients with
SSPE diagnosed by CTPA and negative bilateral ultra-
sound of the legs is currently evaluated in an ongoing
trial [13], but whether this approach is applicable to pa-
tients with small PE diagnosed by V/P SPECT has not
yet been assessed.
In 898 patients diagnosed with PE by V/P SPECT, we
previously reported risk of recurrence and bleeding in
307 patients with small PE undergoing home treatment
with AC [14]. We now report a retrospective follow-up
of patients with PE diagnosed by V/P SPECT in whom
conventional long-term AC therapy for different reasons
had been withheld.
Methods
All consecutive 898 patients with acute PE diagnosed by
V/P SPECT between 2007 and 2011 at Lund University
Hospital, Sweden were included in a prospective registry
[14]. V SPECT had been performed after inhalation of
aerosolized 99 m TC-Technegas to the lung in the su-
pine position with acquisition lasting for 11 min, and P
SPECT with a dual-head gamma camera in the supine
position after i.v. administration of 50 MBq 99mTc-
macroaggregated albumin. V SPECT illuminates ventilated
areas and leaves areas with reduced/absent ventilation on
the imaging screen, whereas P SPECT illuminates areas
where blood flow is normal but leaves areas without perfu-
sion on the imaging screen. PE was diagnosed and quanti-
fied by counting segments showing complete or relative
mismatch between ventilation and perfusion defects [8].
After diagnosis, patients were clinically assessed accord-
ing to a pre specified clinical algorithm [14]. Conventional
long-term AC treatment defined as therapeutic doses of
low molecular heparin or vitamin-K antagonist for at least
three months according to current guidelines [1, 12] was
withheld by the clinician if the V/P SPECT result was inter-
preted as falsely positive for technical reasons (non diagnos-
tic for PE), if the perfusion defect was thought to represent
an old and no longer clinically relevant embolization, or if
the embolization was thought to be too clinically irrelevant
to merit treatment. Withholding of long-term treatment
also required that patients were hemodynamically stable,
did not have clinical signs or symptoms of DVT, and that
the extent of perfusion defects in the V/P SPECT images
was less than ≤ 20 % of the pulmonary vascular bed. Based
on these criteria, 54 patients (6 %, mean age 62 ± 19 years,
36 [67 %] women) did not receive conventional long-term
AC therapy. AC treatment of shorter duration was, how-
ever, given to many of these patients during the diagnostic
work-up as summarized in Table 1. Baseline data, clinical
characteristics including retrospective calculation of sPESI
score [15], additional imaging procedures, quantification of
perfusion defects on V/P SPECT, d-dimer, and troponin T/
brain natriuretic peptide (NT-BNP) results were collected
from patient files. Readmissions, recurrent VTE, and death
during 90 days after the final dose of AC therapy were




Twenty (37 %) patients had a predisposing factor for VTE;
active cancer, previous surgery, immobilization, pregnancy,
contraceptive pill use, trauma or previous DVT (Table 1).
Data on concomitant diseases, sPESI scores, and the num-
ber of auxiliary investigations such as D-dimer, compres-
sion ultrasound, contrast phlebography and CTPA are also
shown in Table 1.
Follow-up
No deaths occurred during 90 days of follow up after
the final dose of AC therapy. Seven patients (13 %)
were readmitted to hospital, in 5 cases (9 %) for sus-
pected VTE. One patient (2 %) underwent CTPA,
without signs of PE. Four patients (7 %) underwent
phlebography or ultrasound of the lower extremities,
whereof two (2[4 %]) were diagnosed with DVT neces-
sitating long-term AC therapy (Fig. 1).
One 71 year old man who had received AC for 24 h
was readmitted 38 days after the final AC dose because
of swelling of the left leg, and ultrasound showed DVT
extending up to the external iliac vein provoked by plas-
ter cast immobilization due to a tibial fracture. One
92 years old woman who had received AC for 20 days
was readmitted 52 days after the final dose of AC ther-
apy due to swelling of the right leg. Ultrasound showed
DVT extending up to the common femoral vein.
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Discussion
To our knowledge, this is the first retrospective study in
which withholding of conventional long-term AC therapy
has been clinically evaluated in patients with a diagnosis of
small PE made by V/P SPECT. We report two cases of
DVT during a follow up period of three months (4 %), but
no PE or death. These figures are comparable higher than
what has been reported when AC therapy has been with-
held in SSPE patients diagnosed by CTPA. Goy et al retro-
spectively study reported no recurrences (0 %) among 30
patients but that treatment provoked major bleeding in 2/
43 patients treated with AC [3]. Moreover, Carrier and co-
workers summarized no recurrences in 60 patients with
SSPE diagnosed with CTPA in combination with a negative
compression ultrasonography [4], when reviewing data
from four different reports [10, 16–18]. These low numbers
must be compared with the results of den Exter et al who
reported that 4/116 (3.5 %) patients with SSPE treated with
AC had a recurrent VTE during 3 months follow up chal-
lenging the assumption that SSPE patients have a low risk
profile and better clinical outcome compared to patients
with more proximal PE [19].
In a cross-sectional survey on clinician’s opinions on
SSPE [20], it was shown that physicians are comfortable
with withholding of therapy if the 3 month risk for recur-
rent VTE is <2 %. This means that our algorithm with a
cutoff of <20 % extension of perfusion defects in the V/P
SPECT images leads to a rate of VTE recurrence that
would not be considered acceptable for the majority of cli-
nicians. Whether the use of a lower limit of PE extension
on V/P SPECT such as for example <5 % or <10 % would
have resulted in a lower risk for recurrent DVT remains
to be systematically investigated. The extension of the per-
fusion defects on V/P SPECT in our two patients later di-
agnosed with VTE was <10 %, and use of this cut-off
would therefore not have resulted in any VTE diagnoses
during follow-up in our material.
Whether a normal result on bilateral lower extremity
ultrasonography should be requested before AC therapy
is withheld in patients with confirmed small PE on V/P
SPECT also needs to be further evaluated. Whereas this
strategy has been used after SSPE diagnosis with CTPA
[3] and is currently under further scientific evaluation
[13], none of our two patients later diagnosed with DVT
had undergone ultrasound or phlebography when the
Table 1 Baseline characteristics and duration of anticoagulant
(AC) therapy in 54 patients with small pulmonary embolism
diagnosed by ventilation/perfusion single photon emission
computed tomography (V/P SPECT) who did not receive
conventional long-term AC. N(%)
Predisposing factors for thrombosis
n(%)
Malignancy 7 (13)
Oral contraception 1 (2)












D-dimer 28 (52), negative in total 18
(33)
NT-proBNP 9 (17), negative in total 8 (15)




1 (2), negative in total 1 (2)
CTPA 17 (31), positive in 6 (11)
Risk stratification n(%)
sPESI score 0 12 (22)
sPESI score 1 28 (52)
sPESI score 2 11 (20)
sPESI score 3 2 (4)
sPESI score 4 1 (2)
Duration of anticoagulant therapy n(%)
<48 hours 34 (63)
2–14 days 11 (20)
15–30 days 7 (13)
31–90 days 2 (4)
Fig. 1 Flow diagram of study. PE = Pulmonary embolism, V/P SPECT =
Ventilation/Perfusion single photon emission computed tomography,
AC = Anticoagulant, VTE = Venous thromboembolism, CTPA = Computed
tomography pulmonary angiography, DVT =Deep vein thrombosis
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decision to abstain from long-term AC therapy was
made.
Whether results of the s-PESI score [17] can be used
to predict which patient with small PE that will develop
VTE during follow-up is still unclear. Retrospectively
calculated s-PESI scores differed in the two patients with
VTE during follow-up in our study; zero in the male pa-
tient and three in the female patient. Our male patient
had an elevated D-dimer which was thought to be
caused by concomitant disease, whereas D-dimer was
not assessed in the female patient. The combination of
Wells score [9] and D-dimer in the diagnostic work-up
of PE [1, 12] is only applicable in outpatients without
too many comorbidities.
The results of our study underlines the importance of
the ongoing prospective study [13] performed to evalu-
ate the safety of withholding AC therapy in patients with
SSPE. It is important to note, however, that the results
of this trial will only be applicable in patients in whom
PE is diagnosed by CTPA and in whom serial ultrasound
of the lower extremities is negative. Our results indicate
that the future study results cannot be extrapolated to
patients with small PE diagnosed by V/P SPECT, at least
not without routinely performing bilateral compression
ultrasonography of the lower extremities.
The discrepancies in results between our and previous
[3, 4, 10, 16–19] might also be caused by differences in
the composition of the study populations. When relating
our results to previously published data [10, 15–17, 21],
our patients were of comparable age (62 years vs 65 and
56 years in the studies of Goy et al. [3] and den Exter et
al [19]). The prevalence of malignancy was lower in our
study (13 % vs 28 and 18 %) respectively, however. Fur-
thermore, one third of our patients had congestive heart
failure (CHF) and 17 % had chronic obstructive pulmon-
ary disease (COPD), figures higher than the 9 % for both
CHF and COPD reported by den Exter et al. [19].
Among patients with malignancies and PE, the risk for
recurrent VTE is increased among those with symptom-
atic PE, compared to those with incidentally detected
asymptomatic disease [20]. In our study, however, no
VTE was detected during follow-up of the 7 patients
with known malignancies.
The duration of AC treatment given during diagnostic
work-up and initial hospital care is another important
issue. In the majority (63 %) of our patients who received
less than 48 h of AC therapy, one case of VTE occurred,
whereas the other case of VTE was diagnosed in the group
(13 %) of patients receiving 15-30 days of AC therapy. The
risk of recurrence during the first three months is approxi-
mately 2 % [22], and the concept of generally prescribing
one month of AC to patients diagnosed with small PE
with V/P SPECT, thereby limiting the risk of bleeding, also
needs to be further investigated.
The aim of our retrospective study was not to com-
pare V/P SPECT with CTPA in diagnosis of small PE,
but PE diagnosis made on V/P SPECT nevertheless had
been reassessed with CTPA in 31 % of patients, and was
confirmed in a third of these. This reflects that the clin-
ical decision to withhold long term AC therapy was
made in three different situations after a positive V/P
SPECT; when the result was believed to be non diagnos-
tic, when the perfusion defect was thought to represent
a no longer clinically relevant embolization, and when
the embolization was thought to be clinically irrelevant.
The reason to perform CTPA is most evident in the first
of these three scenarios, and in 11 of our patients the PE
diagnosis was dropped after a negative CTPA. In the 6
patients in whom long-term AC therapy was withheld in
spite of positive results on both V/P SPECT and CTPA,
therapy was withheld by the clinician for the third of the
above reasons.
A recent paper comparing diagnostic performance be-
tween CTPA and V/P SPECT reported that these modal-
ities were equivalent with respect to receiver operating
curves (ROC) analysis, with areas under curve (AUC) of
0.99 (95 % CI 0.96–1.00) and 0.98 (95 % CI 0.94–1.00)
for V/P SPECT and CTPA, respectively [23].
The main study limitation is of course that we con-
ducted a retrospective clinical follow-up, and not a ran-
domized prospective study. Furthermore, as the decision
to withhold conventional long-term AC therapy was
made on different ground, our patient material is hetero-
geneous. Nevertheless, we think that it represents prac-
tice in an often occurring difficult clinical situation.
Conclusions
Withholding of conventional long term AC therapy in
patients diagnosed with small PE with V/P SPECT was
associated with a 4 % risk of VTE diagnosis during
3 months of follow-up. This would not be considered ac-
ceptable for the majority of clinicians, and the concept
can at the present stage therefore not be recommended.
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